The main reason for poor outcome of botulinum toxin therapy in patients with spasticity will be discussed in deep also presenting clinical cases.
At the end of the session participants will be able to:
1 : Recognize the main reason for poor outcome of botulinum toxin therapy
2 : Evaluate the main reason for poor outcome of botulinum toxin therapy
Target audience: Physiatrists, Residents, Medical Students,
CanMEDS Role: Medical Expert
Rajiv Reebye, MD FRCPC
Paul Winston, MD FRCPC
Speaker: Alessandro Picelli (MD, PhD), Associate Professor of Physical and Rehabilitation Medicine at the Department of
Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Association of Physical Medicine & Rehabilitation. You may claim a maximum of 1.0 hour (credits are automatically calculated).
This webinar was co-developed with IPSEN and CANOSC and planned to achieve scientific integrity, objectivity and balance.